JP2014507153A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014507153A5 JP2014507153A5 JP2013554425A JP2013554425A JP2014507153A5 JP 2014507153 A5 JP2014507153 A5 JP 2014507153A5 JP 2013554425 A JP2013554425 A JP 2013554425A JP 2013554425 A JP2013554425 A JP 2013554425A JP 2014507153 A5 JP2014507153 A5 JP 2014507153A5
- Authority
- JP
- Japan
- Prior art keywords
- he4a
- antibody
- polypeptide
- protein
- wfdc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2011/025321 WO2012112160A1 (en) | 2011-02-17 | 2011-02-17 | Compositions and methods of use for determination of he4a |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014507153A JP2014507153A (ja) | 2014-03-27 |
| JP2014507153A5 true JP2014507153A5 (enExample) | 2014-05-29 |
| JP5887364B2 JP5887364B2 (ja) | 2016-03-16 |
Family
ID=46672864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013554425A Active JP5887364B2 (ja) | 2011-02-17 | 2011-02-17 | HE4aの測定のための組成物および使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US9822169B2 (enExample) |
| EP (1) | EP2675911B1 (enExample) |
| JP (1) | JP5887364B2 (enExample) |
| KR (3) | KR102074141B1 (enExample) |
| CN (1) | CN103492582B (enExample) |
| AU (1) | AU2011359350B2 (enExample) |
| BR (1) | BR112013021056B1 (enExample) |
| CA (1) | CA2827618C (enExample) |
| ES (1) | ES2834617T3 (enExample) |
| IL (1) | IL227924B (enExample) |
| RU (1) | RU2650778C2 (enExample) |
| WO (1) | WO2012112160A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7270960B2 (en) * | 2001-08-29 | 2007-09-18 | Pacific Northwest Research Institute | Diagnosis of ovarian carcinomas |
| CA2827618C (en) * | 2011-02-17 | 2019-08-06 | Fujirebio Diagnostics, Inc. | Compositions and methods of use for the determination of he4a |
| CN106432492A (zh) * | 2015-08-07 | 2017-02-22 | 广州瑞博奥生物技术有限公司 | 针对肿瘤标志物建立的抗体组合及其elisa方法 |
| US11435354B2 (en) * | 2016-02-19 | 2022-09-06 | University Of Miyazaki | Adenocarcinoma detection method |
| USD922352S1 (en) * | 2019-01-04 | 2021-06-15 | Dolby Laboratories Licensing Corporation | Speaker |
| WO2020203478A1 (ja) * | 2019-04-02 | 2020-10-08 | コニカミノルタ株式会社 | 病態情報生成方法、病態情報生成システム、he4糖鎖分析キット及びhe4 |
| CN111620939B (zh) * | 2019-10-25 | 2021-01-01 | 南京市妇幼保健院 | 一种用于治疗或辅助治疗卵巢癌的多肽zyx36-58 |
| USD940793S1 (en) * | 2019-11-22 | 2022-01-11 | Microsoft Corporation | Electronic device |
| US20230243835A1 (en) * | 2020-06-23 | 2023-08-03 | Mitsui Chemicals, Inc. | Adenocarcinoma detection method, and examination kit |
| WO2023195629A1 (ko) * | 2022-04-08 | 2023-10-12 | 아주대학교산학협력단 | He4 검출용 펩타이드 및 그 용도 |
| CN117487018B (zh) * | 2023-09-27 | 2024-05-17 | 武汉爱博泰克生物科技有限公司 | 抗人附睾分泌蛋白4的兔单克隆抗体及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5391485A (en) | 1985-08-06 | 1995-02-21 | Immunex Corporation | DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues |
| US7270960B2 (en) | 2001-08-29 | 2007-09-18 | Pacific Northwest Research Institute | Diagnosis of ovarian carcinomas |
| MXPA05011861A (es) * | 2003-05-05 | 2006-02-17 | Probiodrug Ag | Uso de efectores de ciclasas de glutamato y glutaminil. |
| JP4744109B2 (ja) | 2004-07-20 | 2011-08-10 | トヨタ自動車株式会社 | 半導体装置とその製造方法 |
| US7553944B2 (en) * | 2004-07-21 | 2009-06-30 | The University Of Hong Kong | Human virus causing respiratory tract infection and uses thereof |
| ATE408828T1 (de) * | 2005-02-16 | 2008-10-15 | Dana Farber Cancer Inst Inc | Verfahren zur erkennung eines ovarialkarzinoms |
| EP2982761B1 (en) | 2006-01-04 | 2017-10-04 | Fujirebio America, Inc. | Use of he4 and other biochemical markers for assessment of endometrial and uterine cancers |
| AU2007211085A1 (en) | 2006-01-27 | 2007-08-09 | Tripath Imaging, Inc. | Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor |
| KR20100015438A (ko) * | 2007-03-09 | 2010-02-12 | 트리패스 이미징, 인코포레이티드 | He4 모노클로날 항체 및 이의 사용 방법 |
| EP2126577B1 (en) | 2007-03-29 | 2013-03-13 | Fujirebio Diagnostics, Inc. | Use of he4 for assessment of breast cancers |
| CA2809368C (en) * | 2010-08-26 | 2021-08-24 | University Of Washington Through Its Center For Commercialization | Methods for detecting anti-he4 antibodies and methods of diagnosis and/or prognosis of conditions associated with he4-expressing cells |
| CA2827618C (en) * | 2011-02-17 | 2019-08-06 | Fujirebio Diagnostics, Inc. | Compositions and methods of use for the determination of he4a |
| US9980982B2 (en) * | 2011-06-06 | 2018-05-29 | Women & Infants Hospital Of Rhode Island | HE4 based therapy for malignant disease |
-
2011
- 2011-02-17 CA CA2827618A patent/CA2827618C/en active Active
- 2011-02-17 BR BR112013021056-7A patent/BR112013021056B1/pt active IP Right Grant
- 2011-02-17 RU RU2013142334A patent/RU2650778C2/ru active
- 2011-02-17 KR KR1020187002826A patent/KR102074141B1/ko active Active
- 2011-02-17 CN CN201180070210.2A patent/CN103492582B/zh active Active
- 2011-02-17 WO PCT/US2011/025321 patent/WO2012112160A1/en not_active Ceased
- 2011-02-17 KR KR1020137024824A patent/KR101854110B1/ko active Active
- 2011-02-17 ES ES11858800T patent/ES2834617T3/es active Active
- 2011-02-17 US US13/985,983 patent/US9822169B2/en active Active
- 2011-02-17 JP JP2013554425A patent/JP5887364B2/ja active Active
- 2011-02-17 EP EP11858800.3A patent/EP2675911B1/en active Active
- 2011-02-17 KR KR1020207002847A patent/KR20200013118A/ko not_active Ceased
- 2011-02-17 AU AU2011359350A patent/AU2011359350B2/en active Active
-
2013
- 2013-08-12 IL IL227924A patent/IL227924B/en active IP Right Grant
-
2017
- 2017-10-19 US US15/788,389 patent/US20180057575A1/en not_active Abandoned
-
2020
- 2020-07-01 US US16/918,503 patent/US20200325215A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014507153A5 (enExample) | ||
| JP7242573B2 (ja) | Ror1抗体 | |
| CA2827618C (en) | Compositions and methods of use for the determination of he4a | |
| CN113272332B (zh) | 抗Claudin18.2的抗体及其应用 | |
| JP2024500512A (ja) | 抗b7-h3抗体およびその使用 | |
| WO2025015726A1 (zh) | 抗cd19抗体的抗体、抗cd22抗体的抗体及其应用 | |
| EP4069745A1 (en) | Compositions and methods for transferrin receptor 1 targeting | |
| JP3996649B2 (ja) | 腫瘍関連抗原に対するモノクローナル抗体、その製造方法およびその使用 | |
| JP2022124478A (ja) | 成人スティル病の検査方法及び検査キット | |
| JP6967523B2 (ja) | Aimp2−dx2タンパク質に特異的に結合する抗体 | |
| TWI782000B (zh) | 抗gpr20抗體、其製造方法及其應用 | |
| CN113527481B (zh) | 抗人nkx3.1单克隆抗体及其制备方法和应用 | |
| JP3920556B2 (ja) | 短縮型ミッドカイン(tMK)タンパク質特異的モノクローナル抗体及びその用途 | |
| JP2024513880A (ja) | 免疫組織化学法およびkir3dl2特異的薬剤 | |
| JP5956424B2 (ja) | 抗体、乳がんの治療に用いられる医薬組成物、腫瘍検査方法、及び、腫瘍検査用試薬 | |
| CN119462920B (zh) | 抗p16蛋白抗体及其制备方法和应用 | |
| CN118027205B (zh) | 特异性结合crept的抗体及其用途 | |
| CN112079928B (zh) | 一种抗pd-l1的单克隆抗体 | |
| CN114213542B (zh) | Cps-i抗体及其用途 | |
| KR102688094B1 (ko) | Cobll1 단백질 특이 항체 또는 이의 항원 결합 단편, 및 이의 용도 | |
| WO2022268200A1 (zh) | 针对密蛋白18.2的抗体及其用途 | |
| WO2025218662A1 (zh) | 抗成纤维细胞生长因子受体2b的抗体及其用途 | |
| JP2024544961A (ja) | 抗cldn18.2モノクローナル抗体およびその使用 | |
| CN118255886A (zh) | 抗msln纳米抗体及其制备方法与用途 | |
| KR20250122026A (ko) | 고양이 혈청 아밀로이드 a 단백질에 대한 단일클론항체, 이를 생산하는 융합 세포주 및 이의 용도 |